Stocktoria
Edgewise Therapeutics, Inc. EWTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-03-26
Edgewise Therapeutics, Inc. statistics & valuation
Market cap$4.5B
P / B8.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -30.4% | -27.5% | -29.5% | -18.4% | -15.0% |
| Return on equity | -32.1% | -29.1% | -31.4% | -19.5% | -15.6% |
| Current ratio | 19.85 | 19.93 | 19.50 | 21.53 | 26.97 |
Source: SEC EDGAR filings · CIK 0001710072 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.